The Emergence of the Metabolic Syndrome with Menopause
The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
Women with the metabolic syndrome (central obesity, insulin resistance, and dyslipidemia) are known to be at especially high risk for cardiovascular disease (CVD). The prevalence of the metabolic syndrome increases with menopause and may partially explain the apparent acceleration in CVD after menopause. The transition from pre- to postmenopause is associated with the emergence of many features of the metabolic syndrome, including 1) increased central (intraabdominal) body fat; 2) a shift toward a more atherogenic lipid profile, with increased low density lipoprotein and triglycerides levels, reduced high density lipoprotein, and small, dense low density lipoprotein particles; 3) and increased glucose and insulin levels. The emergence of these risk factors may be a direct result of ovarian failure or, alternatively, an indirect result of the metabolic consequences of central fat redistribution with estrogen deficiency. It is unclear whether the transition to menopause increases CVD risk in all women or only those who develop features of the metabolic syndrome. This article will review the features of the metabolic syndrome that emerge with estrogen deficiency. A better understanding of these metabolic changes with menopause will aid in the recognition and treatment of women at risk for future CVD, leading to appropriate interventions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Disturbances of this metabolic signal lead to the development of metabolic syndrome and a higher cardiovascular risk in women.”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [31]
Citations
Cites
3 retracted
Changes in energy balance and body composition at menopause: a controlled longitudinal study.
Poehlman, E. T., Toth, M. J., & Gardner, A. W. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-9-199511010-00005 · Cited by 520 · cited 4×
“Several groups have shown increased fasting insulin (22, 48) and increased fasting glucose levels (37, 63) in postmenopausal compared with premenopausal women, which would imply worsened insulin resistance with the menopause.”
BackgroundInfluentialRetractedMenopause, energy expenditure, and body composition
Poehlman, E. T. (2002) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2002.810705.x · Cited by 137 · cited 1×
“Menopause is also associated with reduced lean body mass (muscle) and this appears to be related to decreased physical activity (36).”
BackgroundRetractedPoehlman, É. T., Toth, M., Ades, P. A., & Rosen, C. J. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1160662.x · Cited by 128 · cited 4×
“sociated with weight gain, most studies do not reveal increases in BMI independent of normal aging (23, 24).”
BackgroundInfluentialRetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · cited 1×
“Although syndrome X was initially coined by Gerald Reaven in 1988 (16), the features of the metabolic syndrome were first described by Vague (17) and have subsequently been called the insulin resistance syndrome, the central obesity syndrome, and the deadly quartet.”
BackgroundThe metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033 · cited 1×
“The metabolic syndrome may not be a single disease entity, but, rather, a constellation of closely related risk factors that together convey substantially increased cardiovascular risk after accounting for traditional CVD risk factors (12).”
BackgroundPark, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074 · cited 3×
“The metabolic syndrome is estimated to affect approximately 20–30% of the middle-aged population (10), and prevalence appears to be increasing in the U.”
BackgroundInfluentialChambless, L. E., Heiss, G., Folsom, A. R., Rosamond, W., Szklo, M., Sharrett, A. R., & Clegg, L. X. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009302 · Cited by 1,990
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Cited by
Items 101–200 of 1,001
Tissue-Specific Effects of Loss of Estrogen during Menopause and Aging
Wend, K., Wend, P., & Krum, S. A. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00019 · Cited by 118
“Genetically manipulated mice with a loss in E2 signaling induced by Cyp19a1 or ERα deficiency are characterized by increased visceral adiposity, insulin resistance and impaired glucose tolerance, which among others are features of the metabolic syndrome (Carr, 2003).”
BackgroundThe role of sex steroids in white adipose tissue adipocyte function
Newell-Fugate, A. E. (2017) · Reproduction · doi:10.1530/rep-16-0417 · Cited by 114
“Menopause not only results in an increased accumulation of WAT but also puts women at an increased risk of glucose intolerance and decreased insulin sensitivity (Tchernof & Poehlman 1998, Carr 2003).”
BackgroundMetabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype
Dibaba, D. T., Ogunsina, K., Braithwaite, D., & Akinyemiju, T. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-5056-8 · Cited by 113
“The hormonal changes associated with menopause may also lead to central adiposity [39], and is seen as a driving factor for MetS after menopause [40].”
BackgroundReproductive and dietary determinants of the age at menopause in EPIC-Heidelberg
Nagel, G., Altenburg, H.-P., Nieters, A., Boffetta, P., & Linseisen, J. (2005) · Maturitas · doi:10.1016/j.maturitas.2005.05.013 · Cited by 117
Rendina, D., Mossetti, G., FILIPPO, G. D., Benvenuto, D., Vivona, C. L., Imbroinise, A., Zampa, G., Ricchio, S., & Strazzullo, P. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn548 · Cited by 118
Gorres, B. K., Bomhoff, G. L., Morris, J. K., & Geiger, P. C. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2010.199018 · Cited by 116
“Following menopause, a significant decline in insulin sensitivity occurs along with a corresponding increase in fat mass (Lindheim et al. 1994; Carr 2003; Alonso et al. 2006; Moreno et al. 2010).”
BackgroundInfluentialTissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice
Kim, J. H., Meyers, M. S., Khuder, S. S., Abdallah, S. L., Muturi, H. T., Russo, L., Tate, C. R., Hevener, A. L., Najjar, S. M., Leloup, C., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.12.009 · Cited by 112
“Apart from causing degeneration of the cardiovascular, skeletal and central nervous systems [1,2], estrogen deficiency also increases risk for metabolic syndrome and type 2 diabetes [3].”
BackgroundHeianza, Y., Arase, Y., Kodama, S., Hsieh, S. D., Tsuji, H., Saito, K., Shimano, H., Hara, S., & Sone, H. (2013) · Diabetes Care · doi:10.2337/dc13-1048 · Cited by 108
“Because the transition from the premenopausal to the postmenopausal state is associated with changes in body composition (increased body fat mass, increased abdominal fat, and decreased lean body mass) (3) and substantial metabolic changes, features of metabolic syndrome would occur in many women (17).”
BackgroundMenopause, obesity and inflammation: interactive risk factors for Alzheimer’s disease
Christensen, A., & Pike, C. J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00130 · Cited by 108
“, Carroll, J. C., Rosario, E. R., and Barron, A.M. (2009). Protective actions of sex steroid hormones in Alzheimer’s disease.”
BackgroundInfluentialChu, M. C., Cosper, P., Orio, F., Carmina, E., & Lobo, R. A. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.06.073 · Cited by 113
Insulin resistance: sex matters
Mittendorfer, B. (2005) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/01.mco.0000172574.64019.98 · Cited by 113
Menopause as a predictor of new-onset asthma: A longitudinal Northern European population study
Triebner, K., Johannessen, A., Puggini, L., Benediktsdóttir, B., Bertelsen, R. J., Bifulco, E., Dharmage, S. C., Dratva, J., Franklin, K. A., Gíslason, Þ., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.08.019 · Cited by 119
“Menopause is associatedwith profound hormonal and metabolic changes: estrogen levels are low after menopause, and features of the metabolic syndrome become more prevalent paired with increasing risk of chronic conditions, such as diabetes and cardiovascular diseases.(4) However, our understanding of potential changes…”
BackgroundImpaired estrogen receptor action in the pathogenesis of the metabolic syndrome
Hevener, A. L., Clegg, D. J., & Mauvais-Jarvis, F. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.05.020 · Cited by 112
“As estrogen levels decline during and following menopause, the prevalence of obesity escalates markedly (Carr, 2003; Flegal et al., 2002; Freedman et al., 2002).”
BackgroundMetabolic syndrome throughout the menopausal transition: influence of age and menopausal status
Mesch, V., Boero, L. E., Siseles, N., Royer, M., de Prada, M. G., Sayegh, F., Schreier, L. E., Benencia, H., & Berg, G. A. (2006) · Climacteric · doi:10.1080/13697130500487331 · Cited by 119
The Role of Estrogen and Estrogen Receptors on Cardiomyocytes: An Overview
Luo, T., & Kim, J. K. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.10.021 · Cited by 124
Gender Differences and Cardiometabolic Risk: The Importance of the Risk Factors
Meloni, A., Dessalvi, C. C., Cugusi, L., Donataccio, M. P., Deidda, M., Sciomer, S., Gallina, S., Vassalle, C., Moscucci, F., Mercuro, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021588 · Cited by 124
Cardiovascular Benefits of Exercise Training in Postmenopausal Hypertension
Lin, Y.-Y., & Lee, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092523 · Cited by 116
“Women’s weight gain after menopause is a well-recognized phenomenon which is accompanied by a multitude of changes in body composition [13].”
BackgroundCardiolipin, Perhydroxyl Radicals, and Lipid Peroxidation in Mitochondrial Dysfunctions and Aging
Panov, A. V., & Dikalov, S. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1323028 · Cited by 116
“One of the important features of the metabolic syndrome is a dramatic increase in utilization of fatty acids for production of energy by mitochondria, particularly in women after menopause [106, 107].”
BackgroundYonezawa, R., Wada, T., Matsumoto, N., Morita, M., Sawakawa, K., Ishii, Y., Sasahara, M., Tsuneki, H., Saito, S., & Sasaoka, T. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00638.2011 · Cited by 109
“obesity and onset of type 2 diabetes (2, 7, 23).”
BackgroundHealth in middle-aged and elderly women: A conceptual framework for healthy menopause
Jaspers, L., Daan, N. M. P., van Dijk, G. M., Gazibara, T. M., Muka, T., Wen, K.-X., Meun, C., Zillikens, M. C., van Lennep, J. E. R., Roos‐Hesselink, J. W., et al. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.02.010 · Cited by 122
“Inadditiontoestrogendeficiency,otherriskfactorssuch as low body weight and smoking also contribute to the pathogenesis”
Ho, S. C., Wu, S., Chan, S. G., & Sham, A. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.33 · Cited by 117
Is the current BMI obesity classification appropriate for black and white postmenopausal women?
Evans, E. M., Rowe, D. A., Racette, S. B., Ross, K. M., & McAuley, E. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803208 · Cited by 118
“2 Because the link between increasing BMI and health risk is related to increases in adipose tissue, especially the abdominal depot, the relative accuracy of BMI classifications to reflect adiposity is essential, especially in a population that has increased risk for obesity-related diseases after menopause”
BackgroundMenopause Status Moderates Sex Differences in Tau Burden: A Framingham PET Study
Buckley, R. F., O'Donnell, A., McGrath, E. R., Jacobs, H. I. L., Lois, C., Satizabal, C. L., Ghosh, S., Rubinstein, Z. B., Murabito, J. M., Sperling, R. A., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26382 · Cited by 98
Real, F. G. (2005) · Thorax · doi:10.1136/thx.2005.040881 · Cited by 106
Increased urinary cortisol levels during the menopause transition
Woods, N. F., Carr, M. C., Tao, E. Y., Taylor, H. J., & Mitchell, E. S. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000198490.57242.2e · Cited by 113
“Park and colleagues recently showed an increased prevalence of the metabolic syndrome in postmenopausal women compared to premenopausal women, and this postmenopausal worsening of the metabolic profile may contribute to the future risk of cardiovascular disease.(38,39) Women in the late stage of the menopausal transit…”
BackgroundSelf-citationLow sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women
Weinberg, M. E., Manson, J. E., Buring, J. E., Cook, N. R., Seely, E. W., Ridker, P. M., & Rexrode, K. M. (2006) · Metabolism · doi:10.1016/j.metabol.2006.06.017 · Cited by 101
“The increased prevalence of the metabolic syndrome after menopause may be a direct result of ovarian failure or, alternatively, an indirect result of the metabolic consequences of central fat redistribution with estrogen deficiency (29).”
BackgroundChanging course in ageing research: The Healthy Ageing Phenotype
Franco, O. H., Karnik, K., Osborne, G., Ordovás, J. M., Catt, M., & OUDERAA, F. V. D. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.02.006 · Cited by 118
Brown, K. A., Iyengar, N. M., Zhou, X. K., Gucalp, A., Subbaramaiah, K., Wang, H., Giri, D. D., Morrow, M., Falcone, D. J., Wendel, N. K., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3606 · Cited by 99
Sex differences in lipid metabolism and metabolic disease risk
Sugiyama, M. G., & Agellon, L. B. (2012) · Biochemistry and Cell Biology · doi:10.1139/o11-067 · Cited by 102
“Premenopausal women are generally protected from developing cardiovascular disease and stroke, and there is a nearly 10 year difference in the average age of onset in men and women (Carr 2003; Lloyd-Jones et al. 2010).”
BackgroundDietary patterns and the prevalence of metabolic syndrome in Korean women
Cho, Y. A., Kim, J., Cho, E. R., & Shin, A. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.02.018 · Cited by 107
Bilateral Oophorectomy and the Risk of Incident Diabetes in Postmenopausal Women
Appiah, D., Winters, S. J., & Hornung, C. A. (2014) · Diabetes Care · doi:10.2337/dc13-1986 · Cited by 93
“The postmenopausal years are associated with a rise in fasting insulin and glucose levels, and with increasing visceral adiposity (4).”
BackgroundConceição, M., Bonganha, Vechin, Berton, LixandrÃo, Damas Nogueira, F. R., Souza, Chacon-mikahil, & Libardi (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s44245 · Cited by 93
Chedraui, P. A., Hidalgo, L., Chavez, D., Morocho, N., Alvarado, M., & Huc, A. (2006) · Maturitas · doi:10.1016/j.maturitas.2006.05.008 · Cited by 96
Mandrup, C. M., Egelund, J., Nyberg, M., Lundberg, M. H., Roland, C. B., Løgstrup, S., Bangsbo, J., Suetta, C., Stallknecht, B. M., & Hellsten, Y. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.12.017 · Cited by 106
“The differences in the lipid profile at baseline is somewhat consistent with the literature, as we observed that the LDL-C concentration was highest in the postmenopausal women.1,20 However, HDLC was also higher in the postmenopausal compared with the premenopausal women in accordance with our earlier observations17 b…”
BackgroundResultInfluentialEstrogens protect male mice from obesity complications and influence glucocorticoid metabolism
Dakin, R. S., Walker, B. R., Seckl, J. R., Hadoke, P. W. F., & Drake, A. J. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.102 · Cited by 92
“11 12-15 We used a mouse model of diet-induced obesity to investigate sex differences in susceptibility to the metabolic consequences of obesity by addressing the hypothesis that estrogen treatment in males would ameliorate the adverse effects of diet-induced obesity on metabolic parameters.”
Lim, S.-H., Ha, T. Y., Kim, S.-R., Ahn, J., Park, H. J., & Kim, S. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508066750 · Cited by 101
“Menopausal women have a higher risk of uterine fibroids, fibrocystic breast disease, breast or uterine cancer, CHD and obesity((1,2)).”
BackgroundGender and age impacts on the correlations between hyperuricemia and metabolic syndrome in Chinese
Zhang, Q., Lou, S., Meng, Z., & Ren, X. (2010) · Clinical Rheumatology · doi:10.1007/s10067-010-1660-7 · Cited by 94
“This phenomenon may be a direct result of ovarian failure or an indirect result of fat redistribution from gynoid shape to android shape in body topology with estrogen deficiency [28, 29, 31].”
BackgroundInfluentialGérard, C., Arnal, J., Jost, M., Douxfils, J., Lenfant, F., Fontaine, C., Houtman, R., Archer, D. F., Reid, R. L., Løbo, R. A., et al. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2054413 · Cited by 103
Babaei, P., Mehdizadeh, R., Ansar, M. M., & Damirchi, A. (2010) · Menopause International · doi:10.1258/mi.2010.010028 · Cited by 88
Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women
Hong, S. C., Yoo, S. W., Cho, G. J., Kim, T., Hur, J. Y., Park, Y. K., Lee, K. W., & Kim, S. H. (2007) · Menopause · doi:10.1097/gme.0b013e31802cddca · Cited by 91
Oestrogen Modulates Hypothalamic Control of Energy Homeostasis Through Multiple Mechanisms
Roepke, T. A. (2009) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01814.x · Cited by 90
Moreira, N. C. D. V., Hussain, A., Bhowmik, B., Mdala, I., Siddiquee, T., Fernandes, V. O., Montenegro, R. M., & Meyer, H. E. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.05.043 · Cited by 100
“Furthermore, metabolic changes related to menopause have been linked to an increased risk of MS and CVD [39] andmight also explain the higher prevalence of MS among females in our findings.”
BackgroundGender Differences in Lipid Metabolism and the Effect of Obesity
Magkos, F., & Mittendorfer, B. (2009) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2009.03.001 · Cited by 99
Han, S., Komatsu, Y., Murayama, A., Steffensen, K. R., Nakagawa, Y., Nakajima, Y., Suzuki, M., Oie, S., Parini, P., Vedin, L., et al. (2013) · Hepatology · doi:10.1002/hep.26951 · Cited by 90
“The onset of menopause in women markedly increases their risk of developing pathologies associated with MetS, such as obesity, cardiovascular disease, and type 2 diabetes.(33) These risks are reduced by hormone replacement therapy, demonstrating the importance of functional E2 signaling in metabolic tissues.”
BackgroundChedraui, P. A., Hidalgo, L. A., Chavez, D., Morocho, N., Alvarado, M., & Huc, A. (2006) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-006-0239-7 · Cited by 93
“During the menopausal transition there is an emergence of features related to this syndrome such as hypertension, hyperinsulinism, atherogenic lipid proWles and diabetes, which in turn increase cardiovascular risk [7, 31].”
BackgroundPrevalência de síndrome metabólica em uma área rural do semi-árido baiano
de Oliveira, E. P., de Souza, M. L. A., & de Lima, M. D. D. A. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000300008 · Cited by 151
Di-(2-Ethylhexyl)-Phthalate (DEHP) Causes Impaired Adipocyte Function and Alters Serum Metabolites
Klöting, N., Hesselbarth, N., Gericke, M. T., Kunath, A., Biemann, R., Chakaroun, R., Kosacka, J., Kovacs, P. L., Kern, M., Stümvoll, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143190 · Cited by 95
“Estrogens are recognized as key regulators of energy balance and glucose homeostasis since estrogen deficiency promotes visceral adiposity and insulin resistance in menopausal women [31].”
BackgroundObesity, metabolic complications and the menopause: an opportunity for prevention
Teede, H. J., Lombard, C. B., & Deeks, A. A. (2009) · Climacteric · doi:10.3109/13697130903296909 · Cited by 101
Menopause, the metabolic syndrome, and mind-body therapies
Innes, K. E., Selfe, T. K., & Taylor, A. G. (2008) · Menopause · doi:10.1097/01.gme.0b013e318166904e · Cited by 85
The metabolic syndrome among postmenopausal women in Ecuador
Hidalgo, L., Chedraui, P. A., Morocho, N., Alvarado, M., Chavez, D., & Huc, A. (2006) · Gynecological Endocrinology · doi:10.1080/09513590600890272 · Cited by 86
“During the menopausal transition there is an emergence of features related to the metabolic syndrome which in turn increase CVD risk, such as obesity, atherogenic lipid profiles, diabetes, hyperinsulinism and hypertension [8,9].”
BackgroundRespiratory health in women: from menarche to menopause
Macsali, F., Svanes, C., Bjørge, L., Omenaas, E. R., & Real, F. G. (2012) · Expert Review of Respiratory Medicine · doi:10.1586/ers.12.15 · Cited by 69
“78 Degano B, Mourlanette P, Valmary S, Pontier S, Prevost MC, Escamilla R. Differential effects of low and high-dose estradiol on airway reactivity in ovariectomized rats. Respir. Physiol. Neurobiol. 138(2–3), 265–274 (2003).”
BackgroundInfluentialShrestha, S., Ehlers, S. J., Lee, J., Fernández, M. L., & Koo, S. I. (2009) · Journal of Nutrition · doi:10.3945/jn.108.103341 · Cited by 95
Kim, H.-Y., Lee, J., & Kim, J. (2018) · Nutrients · doi:10.3390/nu10050648 · Cited by 84
“After menopause, the lack of estrogen has been shown to alter fat metabolism and promote MetS [36].”
BackgroundGiordano, R., Marzotti, S., Balbo, M., Romagnoli, S., Marinazzo, E., Berardelli, R., Migliaretti, G., Benso, A., Falorni, A., Ghigo, E., et al. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345773 · Cited by 84
Metabolic health, menopause, and physical activity—a 4-year follow-up study
Hyvärinen, M., Juppi, H., Taskinen, S., Karppinen, J. E., Karvinen, S. M., Tammelin, T., Kovanen, V., Aukee, P., Kujala, U. M., Rantalainen, T., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-01022-x · Cited by 91
“, decrease in the systemic estradiol (E2) levels) have been associated with unfavorable changes in several indicators of metabolic health [8, 9].”
BackgroundLong-term Toxicity of Cancer Treatment in Older Patients
Shahrokni, A., Wu, A. J.-C., Carter, J., & Lichtman, S. M. (2015) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2015.08.005 · Cited by 88
Obesity is Related to Increased Menopausal Symptoms among Spanish Women
Fernández‐Alonso, A. M., Cuadros, J. L., Chedraui, P. A., Mendoza, M., Cuadros, Á. M., & Pérez-López, F. R. (2010) · Menopause international · doi:10.1258/mi.2010.010029 · Cited by 92
Chu, M. C., Cosper, P., Nakhuda, G. S., & Lobo, R. A. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.04.043 · Cited by 82
Adipocyte Fatty Acid Storage Factors Enhance Subcutaneous Fat Storage in Postmenopausal Women
Santosa, S., & Jensen, M. D. (2013) · Diabetes · doi:10.2337/db12-0912 · Cited by 82
Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives
Venetsanaki, V., & Polyzos, S. A. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161116666180711121949 · Cited by 79
Nusrianto, R., Ayundini, G., Kristanti, M., Astrella, C., Amalina, N., Muhadi, M., Riyadina, W., Tahapary, D. L., & Soewondo, P. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107798 · Cited by 93
Rönn, M., Lind, L., Örberg, J., Kullberg, J., Söderberg, S., Larsson, A. O., Johansson, L. O. M., Ahlström, H. K., & Lind, P. (2014) · Chemosphere · doi:10.1016/j.chemosphere.2014.03.042 · Cited by 89
“In women decreased levels of estrogen after menopause increase the incidence of obesity and risk for the metabolic syndrome (Carr, 2003).”
BackgroundKhalafi, M., Malandish, A., & Rosenkranz, S. K. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111398 · Cited by 79
Age-dependent sex differences in cardiometabolic risk factors
Zhernakova, D. V., Sinha, T., Andreu‐Sánchez, S., Prins, J. R., Kurilshikov, A., Balder, J.-W., Sanna, S., Study, L. C., Franke, L., Kuivenhoven, J. A., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00131-8 · Cited by 82
Association between tamoxifen treatment and diabetes: A population‐based study
Lipscombe, L. L., Fischer, H. D., Yun, L., Gruneir, A., Austin, P., Paszat, L., Anderson, G. M., & Rochon, P. A. (2012) · Cancer · doi:10.1002/cncr.26559 · Cited by 79
“The decline in estrogen after menopause is also associated with weight gain, insulin resistance, and the metabolic syndrome.(26) Moreover, postmenopausal estrogen replacement has been shown to reduce the incidence of diabetes in clinical trials.”
BackgroundKimura, T., Matsumoto, T., Akiyoshi, M., Owa, Y., Miyasaka, N., Asô, T., & Moritani, T. (2006) · European Journal of Applied Physiology · doi:10.1007/s00421-006-0207-8 · Cited by 92
“The epidemiological data show that women below the age of 50 years rarely develop cardiovascular disease, but the incidence is equal in men and women, 70 years of age (Carr 2003).”
BackgroundInfluentialDrew, B. G., Hamidi, H., Zhou, Z., Villanueva, C. J., Krum, S. A., Calkin, A. C., Parks, B. W., Ribas, V., Kalajian, N. Y., Phun, J., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.606459 · Cited by 78
“Normally cycling females are partially protected against these diseases, but much of this protection is lost following menopause when increased adipose tissue weight gain, tissue inflammation, and metabolic dysfunction manifests (47).”
BackgroundCampbell, B. K., Hernandez-Medrano, J. H., Onions, V. J., Pincott‐Allen, C., Aljaser, F., Fisher, J., McNeilly, A. S., WEBB, R., & Picton, H. M. (2014) · Human Reproduction · doi:10.1093/humrep/deu144 · Cited by 80
“…Gynaecology, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK 2School of Chemistry, University of Leeds, Leeds LS2 9JT, UK 3MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh EH16 4TJ, UK 4Division of Animal Science, School of Biosciences, University of…”
BackgroundDoes accelerated reproductive aging underlie premenopausal risk for cardiovascular disease?
Bleil, M. E., Gregorich, S. E., McConnell, D. S., Rosen, M. P., & Cedars, M. I. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31828950fa · Cited by 86
Woo, Y., Seo, H.-J., McIntyre, R., & Bahk, W.-M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010080 · Cited by 79
“Studies in postmenopausal women have shown a reversal of increased adipocytokines caused by increased visceral adiposity during menopause [40] with repletion of estrogen [41,42] and a specific anti-inflammatory action of estrogen on the brain [43,44].”
BackgroundSmith, A. W., Bosch, M. A., Wagner, E. J., Rønnekleiv, O. K., & Kelly, M. J. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00281.2013 · Cited by 79
Sex Hormones, Insulin Sensitivity, and Diabetes Mellitus
Bruns, C. M., & Kemnitz, J. W. (2004) · ILAR Journal · doi:10.1093/ilar.45.2.160 · Cited by 79
“There is an increase in glucose and insulin levels associated with the menopausal transition (Carr 2003), which may be related to changes in body composition (Poehlman et al. 1995).”
BackgroundAssociation of Leptin Levels With Radiographic Knee Osteoarthritis Among a Cohort of Midlife Women
Karvonen-Gutierrez, C. A., Harlow, S. D., Mancuso, P., Jacobson, J. A., de Leon, C. F. M., & Nan, B. (2013) · Arthritis Care & Research · doi:10.1002/acr.21922 · Cited by 88
“expenditure (12), changes in body composition and topology (13,14), and increased risk of metabolic syndrome (15).”
BackgroundTime course of liver lipid infiltration in ovariectomized rats: Impact of a high-fat diet
Paquette, A., Shinoda, M., RABASA-LHORET, R. P. R., Prud’homme, D., & Lavoie, J.-M. (2007) · Maturitas · doi:10.1016/j.maturitas.2007.08.002 · Cited by 86
“Progressive withdrawal of strogens during peri-menopause has also been associted with many features of the metabolic syndrome, ncluding a shift toward central fat accumulation, nsulin resistance, hyperinsulinemia, as well as the eteriorations of the blood lipid profile [5,6].”
BackgroundShen, H., Huang, S.-Y., Kung, C.-W., Chen, S., Chen, Y., Cheng, P., Lam, K., & Lee, Y. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.02.001 · Cited by 83
Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?
Anagnostis, P. G., Paschou, S. Α., Katsiki, N., Krikidis, D., Lambrinoudaki, I. V., & Goulis, D. G. (2018) · Current Vascular Pharmacology · doi:10.2174/1570161116666180709095348 · Cited by 83
Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations
Bordeleau, L. J., Lipscombe, L. L., Lubiński, J., Ghadirian, P., Foulkes, W. D., Neuhausen, S. L., Ainsworth, P., Pollak, M., Sun, P., & Narod, S. A. (2010) · Cancer · doi:10.1002/cncr.25595 · Cited by 85
“Estrogen suppression may also promote diabetes.(15,16) Menopause, which is often induced by chemotherapy, is associated with an increased risk of the metabolic syndrome,(15) and postmenopausal hormone replacement therapy has been shown to lower the risk of diabetes.”
Hodson, L., Banerjee, R., Rial, B., Arlt, W., Adiels, M., Boren, J., Marinou, K., Fisher, C., Mostad, I. L., Stratton, I. M., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002258 · Cited by 74
Ovariectomized rodents as a menopausal metabolic syndrome model. A minireview
Contreras, J. M. D. L. M., Villalobos‐Molina, R., Zarain‐Herzberg, Á., & Balderas‐Villalobos, J. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03879-4 · Cited by 82
Estradiol and high fat diet associate with changes in gut microbiota in female ob/ob mice
Acharya, K. D., Gao, X., Bless, E. P., Chen, J., & Tetel, M. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-56723-1 · Cited by 74
Lipid metabolism in women: A review
van Oortmerssen, J. A. E., Mulder, J. W. C. M., Kavousi, M., & van Lennep, J. E. R. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119213 · Cited by 83
Han, L., Wang, Y., Li, J., Zhang, X., Bian, C., Wang, H., Du, S., & Suo, L. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400088 · Cited by 82
“However, the protective effects of female sex hormones conferred on women dissipate rapidly after the age of 50 [32].”
BackgroundPrevalence and Clinical Characteristics of the Metabolic Syndrome in Middle-Aged Korean Adults
Kwon, H., Park, Y., Lee, H., Lee, J. H., Choi, Y., Ko, S., Lee, J. M., Kim, S. R., Kang, S. Y., Lee, W. C., et al. (2005) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2005.20.4.310 · Cited by 80
Oh, J. Y., Sung, Y., & Lee, H. J. (2013) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2013.28.2.180 · Cited by 87
“180 CVD risk increases markedly in the postmenopausal period because of the sudden decline in the protective effect of estrogen in women [9].”
BackgroundGabriel, K. P., McClain, J. J., Schmid, K. K., Storti, K. L., High, R., Underwood, D. A., Kuller, L. H., & Kriska, A. M. (2010) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/1479-5868-7-53 · Cited by 83
Hevener, A. L., Zhou, Z., Moore, T. M., Drew, B. G., & Ribas, V. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.013 · Cited by 72
Shi, L., Liu, Z. W., Li, Y., Gong, C., Zhang, H., Li, S., Huang, C. Y., & Li, M. (2012) · PubMed · doi:10.3967/0895-3988.2012.04.002 · Cited by 55
The Metabolic Profile in Active Acromegaly is Gender-Specific
Ciresi, A., Amato, M. C., Pivonello, R., Nazzari, E., Grasso, L. F. S., Minuto, F. M., Ferone, D., Colao, A., & Giordano, C. S. D. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2896 · Cited by 74
Leisure-Time Physical Activity is Associated with a Reduced Risk for Metabolic Syndrome
Cho, E. R., Shin, A., Kim, J., Jee, S. H., & Sung, J. (2009) · Annals of Epidemiology · doi:10.1016/j.annepidem.2009.06.010 · Cited by 81
Diabetes abrogates sex differences and aggravates cardiometabolic risk in postmenopausal women
Mascarenhas-Melo, F., Marado, D., Palavra, F., Sereno, J., Coelho, Á., Pinto, R., Teixeira-Lemos, E., Teixeira, F., & Reis, F. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-61 · Cited by 71
“Interestingly, this sex difference, which normally vanishes after menopause, is rapidly lost in premenopausal T2DM patients, with CVD reaching 2- to 5-fold higher rates than in non-diabetic women [12].”
BackgroundInfluentialPolycystic Ovary Syndrome and Weight Management
Moran, L. J., Lombard, C. B., Lim, S., Noakes, M., & Teede, H. J. (2010) · Women's Health · doi:10.2217/whe.09.89 · Cited by 69
“The mechanistic reasons for this are not yet clear, but may include factors such as increased visceral abdominal fat in postmenopausal women, poten tially related to decreased estrogen levels [83].”
BackgroundCancer treatment induced metabolic syndrome: Improving outcome with lifestyle
Westerink, N. L., Nuver, J., Lefrandt, J. D., Vrieling, A. H., Gietema, J. A., & Walenkamp, A. M. E. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.10.011 · Cited by 65
“Chemotherapy may nduce decreased levels of estrogens and testosterone, which are ssociated with central obesity, dyslipidaemia and insulin resisance (Carr, 2003; Laaksonen et al., 2004).”
BackgroundCoffee Consumption and the Risk of Obesity in Korean Women
Lee, J., Kim, H. K., & Kim, J. (2017) · Nutrients · doi:10.3390/nu9121340 · Cited by 82
“Premenopausal estrogen accumulates fat in the hips and thighs, but after menopause, the estrogen deficiency redistributes body fat and promotes abdominal obesity [41].”
BackgroundEstradiol effects on hypothalamic AMPK and BAT thermogenesis: A gateway for obesity treatment?
López, M., & Tena-Sempere, M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.03.014 · Cited by 70
Effect of Different Doses of Aerobic Exercise Training on Total Bilirubin Levels
Swift, D. L., Johannsen, N. M., Earnest, C. P., Blair, S. N., & Church, T. S. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3182357dd4 · Cited by 77
“clinical implications because reduced serum bilirubin levels have been associated with insulin-resistant states such as metabolic syndrome (13) and type 2 diabetes (12), which tend to be more prevalent in postmenopausal women (6,28).”
BackgroundShp2 Controls Female Body Weight and Energy Balance by Integrating Leptin and Estrogen Signals
He, Z., Zhang, S. S., Meng, Q., Li, S., Zhu, H. H., Raquil, M.-A., Alderson, N., Zhang, H., Wu, J., Rui, L., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06712-11 · Cited by 68
“In postmenopausal women or ovariectomized rodents, estrogen deficiency is associated with increased probability of obesity and type 2 diabetes (7, 32).”
BackgroundSymptom Clusters in Ovarian Cancer Patients With Chemotherapy After Surgery: A Longitudinal Survey
Huang, J., Gu, L., Zhang, L., Lu, X., Zhuang, W., & Yang, Y. (2015) · Cancer Nursing · doi:10.1097/ncc.0000000000000252 · Cited by 70
“When a sharp decline in estrogen levels appears after oophorectomy, increased secretion of gonadotropin results.(43) Consequently, autonomic dysfunction represented with flush, sweating, fatigue, irritability, and insomnia occurs.”
BackgroundInteractions Between Age, Sex, Menopause, and Brain Structure at Midlife: A UK Biobank Study
Than, S., Moran, C., Beare, R. J., Vincent, A. J., Collyer, T. A., Wang, W., Callisaya, M. L., Thomson, R. J., Phan, T. G., Fornito, A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa847 · Cited by 73
Dose Effect of Cardiorespiratory Exercise on Metabolic Syndrome in Postmenopausal Women
Earnest, C. P., Johannsen, N. M., Swift, D. L., Lavie, C. J., Blair, S. N., & Church, T. S. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.02.037 · Cited by 76
Nonalcoholic Fatty Liver Disease: A Global Perspective
Wong, W., & Chan, W. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.01.007 · Cited by 74
Metadata
- Authors
- Carr, M. C.
- Affiliations
- University of Washington (US)
- Corresponding author
- Carr, Molly C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06
- Volume
- 88
- Issue
- 6
- Pages
- 2404-2411
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2123609879
- Cited by
- 1,449
- References
- 84
- Citations by year
- 2026: 54 · 2025: 64 · 2024: 55 · 2023: 67 · 2022: 69 · 2021: 69 · 2020: 65 · 2019: 67 · 2018: 86 · 2017: 61 · 2016: 97 · 2015: 91 · 2014: 79 · 2013: 84 · 2012: 86
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- metabolic syndrome, menopause, estrogen deficiency, ovarian failure, abdominal obesity, insulin resistance, dyslipidemia, cardiovascular risk, postmenopausal women, atherogenic lipid profile, small dense LDL, glucose metabolism
- MeSH terms
- Body Composition, Cardiovascular Diseases, Female, Humans, Menopause, Risk Factors, Prevalence, Metabolic Syndrome, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.